Valiant Laboratories Limited has informed the Exchange regarding 'Letter to shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations 2015'.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories has submitted a letter to shareholders as required under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations. This letter is typically dispatched along with the notice of the Annual General Meeting (AGM). It contains prescribed disclosures such as details of directors seeking appointment or reappointment, the explanatory statement, and other relevant information that shareholders need before voting at the AGM. This is a standard regulatory compliance filing and does not involve any business, financial, or operational update.
This is a routine procedural filing with no direct impact on the company's financials or stock price. Shareholders should review the letter for AGM-related details, particularly any proposed director appointments or reappointments that will be voted on.